Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)
Public ClinicalTrials.gov record NCT05032859. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.
Study identification
- NCT ID
- NCT05032859
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 406 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 22, 2021
- Primary completion
- Feb 2, 2023
- Completion
- Feb 7, 2023
- Last update posted
- Sep 1, 2025
2021 – 2023
United States locations
- U.S. sites
- 57
- U.S. states
- 25
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermavant Investigative Site | Birmingham | Alabama | 35244 | — |
| Dermavant Investigative Site | Scottsdale | Arizona | 85255 | — |
| Dermavant Investigative Site | Scottsdale | Arizona | 85260 | — |
| Dermavant Investigative Site | Fort Smith | Arkansas | 72916 | — |
| Dermavant Investigative Site | Cerritos | California | 90702 | — |
| Dermavant Investigative Site | Huntington Beach | California | 92647 | — |
| Dermavant Investigative Site | Lancaster | California | 93534 | — |
| Dermavant Investigative Site | Long Beach | California | 90806 | — |
| Dermavant Investigative Site | Los Angeles | California | 90045 | — |
| Dermavant Investigative Site | San Diego | California | 92123 | — |
| Dermavant Investigative Site | San Francisco | California | 94115 | — |
| Dermavant Investigative Site | Santa Ana | California | 92701 | — |
| Dermavant Investigative Site | Santa Monica | California | 90404 | — |
| Dermavant Investigative Site | Boca Raton | Florida | 33428 | — |
| Dermavant Investigative Site | Delray Beach | Florida | 33484 | — |
| Dermavant Investigative Site | Jacksonville | Florida | 32256 | — |
| Dermavant Investigative Site | Miami | Florida | 33165 | — |
| Dermavant Investigative Site | Miami | Florida | 33173 | — |
| Dermavant Investigative Site | Miami Lakes | Florida | 33014 | — |
| Dermavant Investigative Site | Tampa | Florida | 33607 | — |
| Dermavant Investigative Site | Snellville | Georgia | 30078 | — |
| Dermavant Investigative Site | Evansville | Indiana | 47715 | — |
| Dermavant Investigative Site | Overland Park | Kansas | 66210 | — |
| Dermavant Investigative Site | Lexington | Kentucky | 40517 | — |
| Dermavant Investigative Site | Louisville | Kentucky | 40241 | — |
| Dermavant Investigative Site | Baton Rouge | Louisiana | 70808 | — |
| Dermavant Investigative Site | Baton Rouge | Louisiana | 70809 | — |
| Dermavant Investigative Site | New Orleans | Louisiana | 70115 | — |
| Dermavant Investigative Site | Rockville | Maryland | 20850 | — |
| Dermavant Investigative Site | Detroit | Michigan | 48202 | — |
| Dermavant Investigative Site | Lincoln | Nebraska | 68516 | — |
| Dermavant Investigative Site | Omaha | Nebraska | 68114 | — |
| Dermavant Investigative Site | Las Vegas | Nevada | 89148 | — |
| Dermavant Investigative Site | East Windsor | New Jersey | 08520 | — |
| Dermanvant Investigative Site | Brooklyn | New York | 11203 | — |
| Dermavant Investigative Site | Watertown | New York | 13601 | — |
| Dermavant Investigative Site | Charlotte | North Carolina | 28277 | — |
| Dermavant Investigative Site | Dayton | Ohio | 45414 | — |
| Dermavant Investigative Site | Mason | Ohio | 45040 | — |
| Dermavant Investigative Site | Mayfield Heights | Ohio | 44124 | — |
| Dermavant Investigative Site | Tulsa | Oklahoma | 74114 | — |
| Dermavant Investigative Site | Medford | Oregon | 97504 | — |
| Dermavant Investigative Site | Portland | Oregon | 97210 | — |
| Dermavant Investigative Site | Portland | Oregon | 97239 | — |
| Dermavant Investigative Site | East Greenwich | Rhode Island | 02818 | — |
| Dermavant Investigative Site | Anderson | South Carolina | 29621 | — |
| Dermavant Investigative Site | North Charleston | South Carolina | 29420 | — |
| Dermavant Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Dermavant Investigative Site | Memphis | Tennessee | 38119 | — |
| Dermavant Investigative Site | Bellaire | Texas | 77401 | — |
| Dermavant Investigative Site | Dripping Springs | Texas | 78620 | — |
| Dermavant Investigative Site | Grapevine | Texas | 76051 | — |
| Dermavant Investigative Site | Houston | Texas | 77004 | — |
| Dermavant Investigative Site | Houston | Texas | 77061 | — |
| Dermavant Investigative Site | San Antonio | Texas | 78213 | — |
| Dermavant Investigative Site | Webster | Texas | 77598 | — |
| Dermavant Investigative Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05032859, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2025 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05032859 live on ClinicalTrials.gov.